GlassScriptPhysician profile
Michael Clenshaw
NPI 1942798145
$2,116.05
in general payments reported to CMS, 2019-2025
7 companies · $1,275 in 2025
The $1,275 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $262 · 2023: $149 · 2024: $431 · 2025: $1,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455 · Education: $375 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.43 |
| Education | $375.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,555.28 | 2022-2025 | Endurant Iis, Valiant Captivia, Hawkone |
| Cumberland Pharmaceuticals, INC. | $149.11 | 2023 | Caldolor |
| Atricure, INC. | $125.00 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Boston Scientific Corporation | $98.24 | 2025 | Accolade Sr |
| Imperative Care, INC | $46.17 | 2025 | Symphony Catheter, Prodigy Catheter |
| Bolton Medical INC | $17.25 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Clenshaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.